DRAP suggests 38 pc reduction in Remdesivir injection price: sources

ISLAMABAD: Drug Regulatory Authority of Pakistan (DRAP) has suggested a 38 per cent cut in 100 mg Remdesivir injection price and recommended to set its price up to Rs5,680.

The federal government has decided to approve a major reduction in prices of Remdesivir injection used to treat COVID-19 patients as a summary was sent to the federal cabinet by the health ministry, sources privy to the development.

The federal cabinet is likely to approve the summary for making a cut in the injection’s price up to Rs3,564.

According to the DRAP summary, it has been recommended to fix the price up to Rs5,680 for a vial of 100 mg Remdesivir injection following a decline in its rate globally. Earlier, the federal cabinet had fixed its price up to Rs10,873 on June 16.

The summary prepared by DRAP policy board on November 9 stated that the authority had decreased its price up to Rs9,244 from Rs10,873 on August 17, as of now, the price of Remdesivir injection falls from $50 to $35 globally.

Prime Minister Imran Khan summoned a session of the federal cabinet today in order to discuss a 14-point agenda which includes mulling over the reduction in injections’ prices for COVID-19 patients, as well as reviewed notification regarding rates of medicines, it was learnt earlier in the day.